Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes

Código QR

Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes

Cátia Cristina Silva Sousa Vergara Palma,1 Pablo Moura Lopes,2 Eliete Leão Clemente Silva,1 Maria de Fátima da Matta Bevilaqua,1 Alfredo de Souza Bomfim,2 Marilia Brito Gomes1 1Department of Internal Medicine, Diabetes Unit, State University Hospital of Rio de Janeir...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Palma CCSSV, Lopes PM, Silva ELC, Bevilaqua MFM, Bomfim AS, Gomes MB
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	vascular age type 2 diabetes cardiovascular risk cimt Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/e6f704fee2be4a0c8c287fceb23e7957
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout
por: Gancheva R., et al.
Publicado: (2019)

Attainment of recommended therapeutic targets of modifiable cardiovascular risk factors among individuals with type 2 diabetes mellitus screened at a diabetes clinic in Sri Lanka
por: Weerarathna TP, et al.
Publicado: (2018)

Ideal Cardiovascular Health and Vascular Phenotype Associations in Mothers with Obesity and Their Six-Year-Old Children
por: Litwin L, et al.
Publicado: (2021)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
por: McIntyre HD
Publicado: (2010)

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
por: Avgerinos I, et al.
Publicado: (2019)

Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis
por: Huang H, et al.
Publicado: (2018)

Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
por: Hinnen D, et al.
Publicado: (2019)

Relationship Between Skeletal Muscle Mass to Visceral Fat Area Ratio and Cardiovascular Risk in Type 2 Diabetes
por: Liu D, et al.
Publicado: (2021)

The Epidemic Of The Metabolic Syndrome Among The Palestinians In The Gaza Strip
por: Jamee AS, et al.
Publicado: (2019)

Cardiovascular Safety and Superiority of Anti-Obesity Medications
por: Alobaida M, et al.
Publicado: (2021)

Assessment of Cardiovascular Risk Factors and Their Interactions in the Risk of Coronary Heart Disease in Patients with Type 2 Diabetes with Different Weight Levels, 2013–2018
por: Wang C, et al.
Publicado: (2021)

Clinical utility of metabolic syndrome severity scores: considerations for practitioners
por: DeBoer MD, et al.
Publicado: (2017)

Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes
por: Latika Sibal, et al.
Publicado: (2011)

The Challenges of Identifying Environmental Determinants of Type 1 Diabetes: In Search of the Holy Grail
por: Butalia S, et al.
Publicado: (2020)

An introduction to therapeutic approaches to vascular cognitive impairment
por: Atticus H Hainsworth, et al.
Publicado: (2021)

The Mental Status in Patients with Diabetes Mellitus Admitted to a Diabetes Clinic After Presenting in the Emergency Room: The Application of the SCL-90 Scale
por: Albai O, et al.
Publicado: (2021)

Optimal Body Fat Percentage Cut-Off Values in Predicting the Obesity-Related Cardiovascular Risk Factors: A Cross-Sectional Cohort Study
por: Macek P, et al.
Publicado: (2020)

Management Practice and Contributing Risk Factors for Chronic Complications Among Type 2 Diabetes Mellitus Adult Patients in Follow-Up at a Tertiary Care Teaching Hospital
por: Negash Z, et al.
Publicado: (2020)

Impacts of Pre-Diabetes or Prehypertension on Subsequent Occurrence of Cardiovascular and All-Cause Mortality among Population without Cardiovascular Diseases
por: Huang Y, et al.
Publicado: (2020)

Scutellaria barbata D. Don Polysaccharides Inhibit High Glucose-Induced Proliferation and Angiogenesis of Retinal Vascular Endothelial Cells
por: Li W, et al.
Publicado: (2021)

Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes
por: Malloy J, et al.
Publicado: (2012)

Magnitude of, and Factors Associated with Cardiovascular Disease Among Type Two Diabetes Mellitus Patients
por: Tesfaye A, et al.
Publicado: (2020)

Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication
por: Dessie G, et al.
Publicado: (2021)

Potential role of phytochemicals in metabolic syndrome prevention and therapy
por: Francini-Pesenti F, et al.
Publicado: (2019)

Incremental increases in economic burden parallels cardiometabolic risk factors in the US
por: McQueen RB, et al.
Publicado: (2016)

Derivation and Validation of a Prediction Model for Predicting the 5-Year Incidence of Type 2 Diabetes in Non-Obese Adults: A Population-Based Cohort Study
por: Cai XT, et al.
Publicado: (2021)

Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
por: Zhao H, et al.
Publicado: (2019)

Depression Among Patients with Type 2 Diabetes Mellitus: Prevalence and Associated Factors in Hue City, Vietnam
por: Tran NMH, et al.
Publicado: (2021)

Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk
por: Togfano RJ, et al.
Publicado: (2020)

Developmental origins of health and disease: a new approach for the identification of adults who suffered undernutrition in early life
por: Ferreira HS, et al.
Publicado: (2018)

Nomogram Model for Screening the Risk of Type II Diabetes in Western Xinjiang, China
por: Wang Y, et al.
Publicado: (2021)

Association Between Early Markers of Renal Injury and Type 2 Diabetic Peripheral Neuropathy
por: Yang Z, et al.
Publicado: (2021)

Comparison of the Incidence of Cardiovascular Diseases in Weight Groups with Healthy and Unhealthy Metabolism
por: Wang W, et al.
Publicado: (2021)

Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
por: Cosenso-Martin LN, et al.
Publicado: (2020)

Exosomes from β-cells alleviated hyperglycemia and enhanced angiogenesis in islets of streptozotocin-induced diabetic mice
por: Sun Y, et al.
Publicado: (2019)

Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks
por: Shemesh E, et al.
Publicado: (2019)

Assessment of Cardiovascular Risk Factors in Patients with Type 2 Diabetes in Upper Egypt Villages
por: Hussein A, et al.
Publicado: (2020)

Cardiovascular Risk Prediction, Glycemic Control, and Determinants in Diabetic and Hypertensive Patients in Massawa Hospital, Eritrea: Cross-Sectional Study on 600 Subjects
por: Tesfai B, et al.
Publicado: (2021)

Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel
por: Bojko Bjelakovic, et al.
Publicado: (2021)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
por: Peter J Donovan, et al.
Publicado: (2010)